TRANSITION AND SEPARATION AGREEMENTTransition and Separation Agreement • July 17th, 2015 • Raptor Pharmaceutical Corp • Pharmaceutical preparations • California
This Transition and Separation Agreement (the “Agreement”) is made by and between Thomas E. Daley (“Executive”) and Raptor Pharmaceutical Corp., a Delaware corporation (the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”), effective eight (8) days after Executive’s signature hereto (the “Effective Date”), unless Executive revokes Executive’s acceptance of this Agreement as provided in Section 6(c) below, with reference to the following facts:
